Effects of topical corticosteroids on cell proliferation, cell cycle progression and apoptosis: In vitro comparison on HaCaT

International Journal of Pharmaceutics

Volumn 479, Issue 2, 2015, Pages 422-429

  Guichard, Alexandre ^a,b   Humbert, Philippe ^a,b   Tissot, Marion ^b   Muret, Patrice ^b   Courderot Masuyer, Carole ^c   Viennet, Céline ^b  

^a UNIVERSITY HOSPITAL OF BESANÇON   (France)

^b UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^c Bioexigence   (France)

Author keywords

Apoptosis; Cell cycle; HaCaT; Keratinocyte; Proliferation; Topical corticosteroid

Indexed keywords

BETAMETHASONE DIPROPIONATE; BETAMETHASONE VALERATE; CLOBETASOL PROPIONATE; DESONIDE; HYDROCORTISONE; HYDROCORTISONE BUTYRATE; LIPOCORTIN 5; PROPIDIUM IODIDE; ANTIINFLAMMATORY AGENT; DERMATOLOGICAL AGENT; GLUCOCORTICOID;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE G2 PHASE; CELL CYCLE PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL DEATH; CELL PROLIFERATION; CELL VIABILITY; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DOSE RESPONSE; DRUG CYTOTOXICITY; HUMAN; HUMAN CELL; IN VITRO STUDY; KERATINOCYTE; MTT ASSAY; PRIORITY JOURNAL; TOPICAL TREATMENT; CELL CYCLE; CELL LINE; COMPARATIVE STUDY; DRUG EFFECTS; INTRADERMAL DRUG ADMINISTRATION; METABOLISM;

ADMINISTRATION, CUTANEOUS; ANTI-INFLAMMATORY AGENTS; APOPTOSIS; CELL CYCLE; CELL LINE; CELL PROLIFERATION; DERMATOLOGIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOCORTICOIDS; HUMANS; IN VITRO TECHNIQUES; KERATINOCYTES;

EID: 84923659036     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2014.12.066     Document Type: Article

References (38)

1. W.Y. Almawi, and H. Tamim Posttranscriptional mechanisms of glucocorticoid antiproliferative effects: glucocorticoids inhibit IL-6-induced proliferation of B9 hybridoma cells Cell Transplant. 10 2001 161 164
2. A. Amsterdam, K. Tajima, and R. Sasson Cell-specific regulation of apoptosis by glucocorticoids: implication to their anti-inflammatory action Biochem. Pharmacol. 64 2002 843 850
3. A. Ashkenazi, and V.M. Dixit Death receptors: signaling and modulation Science 281 1998 1305 1308
4. M.J. Ausserlechner, P. Obexer, G. Böck, S. Geley, and R. Kofler Cyclin D3 and c-MYC control glucocorticoid-induced cell cycle arrest but not apoptosis in lymphoblastic leukemia cells Cell Death Differ. 11 2004 165 174
5. P.J. Barnes Anti-inflammatory actions of glucocorticoids: molecular mechanisms Clin. Sci. 94 1998 557 572
6. J. Bartek, and J. Lukas Chk1 and Chk2 kinases in checkpoint control and cancer Cancer Cell. 3 2003 421 429
7. C. Courderot-Masuyer, S. Robin, H. Tauzin, S. Harbon, S. Mac-Mary, and A. Guichard Evaluation of the effects of corticosteroids on histamine release by ex vivo cutaneous microdialysis J. Cosmet. Dermatol. Sci. Appl. 3 2013 228 233
8. J.S. Goodwin, D. Atluru, S. Sierakowski, and E.A. Lianos Mechanism of action of glucocorticosteroids. Inhibition of T cell proliferation and interleukin 2 production by hydrocortisone is reversed by leukotriene B4 J. Clin. Invest. 77 1986 1244 1250
9. D.R. Green Apoptotic pathways: the roads to ruin Cell 94 1998 695 698
10. R. Hein, H.C. Korting, and T. Mehring Differential effect of medium potent nonhalogenated double-ester-type and conventional glucocorticoids on proliferation and chemotaxis of fibroblasts in vitro Skin Pharmacol. 7 1994 300 306
11. M.O. Hengartner The biochemistry of apoptosis Nature 2000 770 776
12. D.J. Hepburn, J.L. Aeling, and W.L. Weston A reappraisal of topical steroid potency Pediatr. Dermatol. 13 1996 239 245
13. T.G. Hofmann, S.P. Hehner, S. Bacher, W. Dröge, and M.L. Schmitz Various glucocorticoids differ in their ability to induce gene expression, apoptosis and to repress NF-kappaB-dependent transcription FEBS Lett. 441 1998 441 446
14. M.J. Kerscher, and H.C. Korting Topical glucocorticoids of the non-fluorinated double-ester type. Lack of atrophogenicity in normal skin as assessed by high-frequency ultrasound Acta Derm. Venereol. 72 1992 214 216
15. H.C. Korting, S. Schindler, A. Hartinger, M. Kerscher, T. Angerpointner, and H.I. Maibach MTT-assay and neutral red release (NRR)-assay: relative role in the prediction of the irritancy potential of surfactants Life Sci. 55 1994 40
16. H.C. Korting, E. Hülsebus, M. Kerscher, R. Greber, and M. Schäfer-Korting Discrimination of the toxic potential of chemically differing topical glucocorticoids using a neutral red release assay with human keratinocytes and fibroblasts Br. J. Dermatol. 133 1995 54 59
17. H.C. Korting, A. Unholzer, M. Schäfer-Korting, I. Tausch, J. Gassmueller, and K.-H. Nietsch Different skin thinning potential of equipotent medium-strength glucocorticoids Skin Pharmacol. Appl. Skin Physiol. 15 2002 85 91
18. N. Kravchenko-Balasha, S. Mizrachy-Schwartz, S. Klein, and A. Levitzki Shift from apoptotic to necrotic cell death during human papillomavirus-induced transformation of keratinocytes J. Biol. Chem. 284 2009 11717 11727
19. K. Lange, A. Gysler, M. Bader, B. Kleuser, H.C. Korting, and M. Schäfer-Korting Prednicarbate versus conventional topical glucocorticoids: pharmacodynamic characterization in vitro Pharm. Res. 14 1997 1744 1749
20. K. Lange, B. Kleuser, A. Gysler, M. Bader, C. Maia, and C. Scheidereit Cutaneous inflammation and proliferation in vitro: differential effects and mode of action of topical glucocorticoids Skin Pharmacol. Appl. Skin Physiol. 13 2000 93 103
21. H. Li, W. Qian, X. Weng, Z. Wu, H. Li, and Q. Zhuang Glucocorticoid receptor and sequential P53 activation by dexamethasone mediates apoptosis and cell cycle arrest of osteoblastic MC3T3-E1 cells PLoS ONE 7 2012 e37030
22. A.W. McKenzieE, and R.B. Stoughton Method for comparing percutaneous absorption of steroids Arch. Dermatol. 86 1962 608 610
23. T. Mosmann Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J. Immunol. Methods 65 1983 63
24. M. Ponec, and J.A. Kempenaar Biphasic entry of glucocorticoids into cultured human skin keratinocytes and fibroblasts Arch. Dermatol. Res. 275 1983 334 344
25. M. Ponec, E.R. De Kloet, and J.A. Kempenaar Corticoids and human skin fibroblasts: intracellular specific binding in relation to growth inhibition J. Invest. Dermatol. 75 1980 293 296
26. M. Ponec, J.A. Kempenaar, and E.R. De Kloet Corticoids and cultured human epidermal keratinocytes: specific intracellular binding and clinical efficacy J. Invest. Dermatol. 76 1981 211 214
27. A. Ramalingam, A. Hirai, and E.A. Thompson Glucocorticoid inhibition of fibroblast proliferation and regulation of the cyclin kinase inhibitor p21Cip1 Mol. Endocrinol. 11 1997 577 586
28. G. Rohaly, J. Chemnitz, S. Dehde, A.M. Nunez, J. Heukeshoven, and W. Deppert A novel human p53 isoform is an essential element of the ATR-intra-S phase checkpoint Cell 122 2005 21 32
29. M. Schäfer-Korting, M.H. Schmid, and H.C. Korting Topical glucocorticoids with improved risk-benefit ratio. Rationale of a new concept Drug Saf. 14 1996 375 385
30. S. Schmidt, J. Rainer, C. Ploner, E. Presul, S. Riml, and R. Kofler Glucocorticoid-induced apoptosis and glucocorticoid resistance: molecular mechanisms and clinical relevance Cell Death Differ. 11 2004 S45 S55
31. R.-G. Shao, C.-X. Cao, T. Shimizu, P.M. O'Connor, K.W. Kohn, and Y. Pommier Abrogation of an S-phase checkpoint and potentiation of camptothecin cytotoxicity by 7-hydroxystaurosporine (UCN-01) in human cancer cell lines, possibly influenced by p53 function Cancer Res. 57 1997 4029 4035
32. M.P. Sherman, C.M. de Noronha, D. Pearce, and W.C. Greene Human immunodeficiency virus type 1 Vpr contains two leucine-rich helices that mediate glucocorticoid receptor coactivation independently of its effects on G(2) cell cycle arrest J. Virol. 74 2000 8159 8165
33. O. Stojadinovic, B. Lee, C. Vouthounis, S. Vukelic, I. Pastar, and M. Blumenberg Novel genomic effects of glucocorticoids in epidermal keratinocytes: inhibition of apoptosis, interferon-gamma pathway, and wound healing along with promotion of terminal differentiation J. Biol. Chem. 282 2007 4021 4034
34. A. Trautmann, M. Akdis, P. Schmid-Grendelmeier, R. Disch, E.B. Bröcker, and K. Blaser Targeting keratinocyte apoptosis in the treatment of atopic dermatitis and allergic contact dermatitis J. Allergy Clin. Immunol. 108 2001 839 846
35. I. Vermes, C. Haanen, and C. Reutelingsperger Flow cytometry of apoptotic cell death J. Immunol. Methods 243 2000 167 190
36. F. Wach, A. Bosserhoff, U. Kurzidym, K. Nowok, M. Landthaler, and R. Hein Effects of mometasone furoate on human keratinocytes and fibroblasts in vitro Skin Pharmacol. Appl. Skin Physiol. 11 1998 43 51
37. X. Ye, A.A. Franco, H. Santos, D.M. Nelson, P.D. Kaufman, and P.D. Adams Defective S phase chromatin assembly causes DNA damage, activation of the S phase checkpoint, and S phase arrest Mol. Cell 11 2003 51
38. M.H. Zulfakar, C.M.Y. Ong, and C.M. Heard The effects of betamethasone dipropionate and fish oil on HaCaT proliferation and apoptosis Int. J. Pharm. 434 2012 399 405